Sunday, February 26, 2017 2:12:09 PM
Actipatch is at the right place and time with the recent FDA clearance to virtually have a monopoly in the making with miniaturized pain devices. We are talking billions of dollars and that is no overstatement.
Think a big pharm just might be interested partnering before the Actipatch Back device gets clearance soon?
Times are changing before our eyes within the medical community.
Take cover as an Actipatch tsunami is approaching quickly!
http://www.opb.org/news/article/opioids-pain-pills-lower-back-massage-exercise/
"The American College of Physicians has updated its guidelines for treating lower back pain. The hope is to reduce opioid dependency. The college used to say the first line of defense for back pain was over-the-counter pain relievers or opioids, depending on the severity of the pain. But now it wants doctors to avoid prescribing drugs."
"One of the study’s authors, Oregon Health and Science University professor Rick Deyo, said the change is aimed at the ongoing opioid epidemic."
“There’s also good evidence that the effectiveness of these drugs in the long-term is simply not exactly what you’d like,” Deyo said. “And at the same time, growing evidence that some of these non-drug therapies really do have some benefit.”
Never buy/sell a stock on my recommendation alone. Always do your own DD and be aware of the risks!
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM